rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    OLMA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Olema Oncology at Stifel 2026 Healthcare Conference 2026: key trial inflection
      Nov 11Investing.comOLMASF
      Olema Oncology at guggenheim healthcare conference: big breast cancer bet
      Nov 10Investing.comOLMA
      Olema Oncology Reports Third Quarter 2026 Financial and Operating Results
      Nov 10Yahoo FinanceOLMA
      Olema Oncology to Present Combination Data from the Palazestrant and OP-3136 Programs at the 2026 San Antonio Breast Cancer Symposium
      Nov 4Yahoo FinanceOLMA
      Olema Oncology to Participate in Upcoming Investor Conferences
      Nov 2Yahoo FinanceOLMA
      The Zacks Analyst Blog Highlights AstraZeneca, Roche, Puma Biotechnology and Olema Oncology
      Oct 19Yahoo FinanceOLMAPBYI
      Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Oct 2Yahoo FinanceOLMA
      Olema Pharmaceuticals (OLMA) Receives a Rating Update from a Top Analyst

      Detailed price information for Olema Pharmaceuticals Inc (OLMA-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailOLMA
      Olema Pharmaceuticals at H.C. Wainwright: pipeline bets on breast cancer
      Sep 16Investing.comOLMA
      Goldman Sachs Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)

      Detailed price information for Olema Pharmaceuticals Inc (OLMA-Q) from The Globe and Mail including charting and trades.

      Sep 15The Globe and MailOLMA
      Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results

      Olema Pharmaceuticals (NASDAQ:OLMA) shares fell 15. 1% in pre-market trading to $8.

      Sep 14Yahoo FinanceAZNOLMA
      Stifel cuts Olema Pharmaceuticals price target on trial concerns
      Sep 14Investing.comOLMA
      Why is Olema Pharmaceuticals stock sliding today?
      Sep 14Investing.comOLMA
      Citi Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)

      Detailed price information for Olema Pharmaceuticals Inc (OLMA-Q) from The Globe and Mail including charting and trades.

      Sep 12The Globe and MailOLMA
      Olema Oncology at citigroup summit: palazestrant data, delays
      Sep 10Investing.comOLMAC
      Olema: Best Breast Cancer Therapy, Or SERD Also-Ran? We'll Find Out In Q1'27 (NASDAQ:OLMA)
      Sep 9Seeking AlphaOLMA
      Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Sep 2Yahoo FinanceOLMA
      Olema Oncology to Participate in Upcoming Investor Conferences

      SAN FRANCISCO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage...

      Aug 31BarchartOLMA

      This is the newest page. Registered accounts read further back.